Skip to navigation Skip to main content

Your search for apixaban returned 101 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Post remove

Your search for apixaban returned 101 results

Sort Results:

Relevant Recent
News

Prophylaxis With Apixaban Feasible for Cancer Patients

Publish Date
Primary venous thromboembolism prophylaxis with apixaban, an oral direct Factor Xa inhibitor, in ambulatory cancer patients undergoing first- or second-line chemotherapy for advanced or metastatic cancer, is safe and well tolerated.
News

Apixaban Beats Aspirin for Stroke Prevention in A-Fib

Publish Date
Apixaban is more effective than aspirin in reducing the risk of repeat stroke and systemic embolism in patients with atrial fibrillation (AF) who are unsuitable for vitamin K antagonists (VKA) therapy.
Drugs in the Pipeline

Eliquis Reversal Agent Demonstrates Efficacy in Phase 3 Study

Publish Date
Portola Pharmaceuticals, Bristol-Myers Squibb Company, and Pfizer announced results from the Phase 3 ANNEXA-A (Andexanet Alfa a Novel Antidote to the Anticoagulant Effects of FXa Inhibitors - Apixaban) study with andexanet alfa as a reversal agent for Eliquis (apixaban).